Rescue therapy with sirolimus in a renal transplant recipient with tacrolimus-induced hepatotoxicity

Ines MesarDepartment of Nephrology, Arterial Hypertension, Dialysis and Transplantation, University Hospital Centre Zagreb and School of Medicine, University of Zagreb ZagrebCroatia

Petar KesDepartment of Nephrology, Arterial Hypertension, Dialysis and Transplantation, University Hospital Centre Zagreb and School of Medicine, University of Zagreb ZagrebCroatia

Tvrtko HudolinDepartment of Nephrology, Arterial Hypertension, Dialysis and Transplantation, University Hospital Centre Zagreb and School of Medicine, University of Zagreb ZagrebCroatia

Nikolina Basic-JukicDepartment of Nephrology, Arterial Hypertension, Dialysis and Transplantation, University Hospital Centre Zagreb and School of Medicine, University of Zagreb ZagrebCroatiaCorrespondence[email protected]

References

Meier-Kriesche HU, Ojo AO, Port FK, Arndorfer JA, Cibrik DM, Kaplan B. Survival improvement among patients with end-stage renal disease: trends over time for transplant recipients and wait-listed patients. J Am Soc Nephrol. 2001;12:1293–1296
PubMed Web of Science ®Google Scholar
Sacher VY, Bejarano PA, Pham SM. Tacrolimus induced hepatotoxicity in a patient with bilateral lung transplant. Transpl Int. 2012;25:e111–e112
Web of Science ®Google Scholar
Oto T, Okazaki M, Takata K, et al. Calcineurin inhibitor-related cholestasis complicating lung transplantation. Ann Thorac Surg. 2010;89:1664–1665
PubMed Web of Science ®Google Scholar
Lorber MI, Van Buren CT, Flechner SM, Williams C, Kahan BD. Hepatobiliary and pancreatic complications of cyclosporine therapy in 466 renal transplant recipients. Transplantation. 1987;43:35–40
PubMed Web of Science ®Google Scholar
Serrano T, Mitry RR, Terry C, Lehec SC, Dhawan A, Hughes RD. The effects of immunosuppressive agents on the function of human hepatocytes in vitro. Cell Transplant. 2006;15:777–783
PubMed Web of Science ®Google Scholar
Chang HR, Lin CC, Lian JD. Lack of hepatotoxicity upon sirolimus addition to a calcineurin inhibitor-based regimen in hepatitis virus-positive renal transplant recipients. Transplant Proc. 2007;39:1520–1522
PubMed Web of Science ®Google Scholar
Niemczyk M, Wyzgał J, Perkowska A, Porowski D, Paczek L. Sirolimus-associated hepatotoxicity in the kidney graft recipient. Transpl Int. 2005;18:1302–1303
PubMed Web of Science ®Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Rescue therapy with sirolimus in a renal transplant recipient with tacrolimus-induced hepatotoxicity

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Rescue therapy with sirolimus in a renal transplant recipient with tacrolimus-induced hepatotoxicity

References

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date